Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy

BACKGROUND: Most thalassemic patients with chronic hepatitis C virus (HCV) infection do not respond to therapy with pegylated interferon (Peg-IFN) plus ribavirin (RBV) due to hepatic siderosis and RBV dose reduction caused by RBV-induced anemia. OBJECTIVES: In the present study, we recruited HCV gen...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hepat Mon
Hoofdauteurs: Sandoughdaran, Saleh, Alavian, Seyed Moayed, Sharafi, Heidar, Behnava, Bita, Salimi, Shima, Mehrnoush, Leila, Karimi Elizee, Pegah, Keshvari, Maryam
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Kowsar 2015
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4344648/
https://ncbi.nlm.nih.gov/pubmed/25741371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.23564
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items